New Jersey Assembly Bill 2488 (Prior Session Legislation)

---

Spectrum: Moderate Partisan Bill (Democrat 4-1)
Status: Introduced on February 3 2020 - 25% progression, died in committee
Action: 2020-02-03 - Introduced, Referred to Assembly Health Committee
Pending: Assembly Health Committee
Text: Latest bill text (Introduced) [HTML]

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Rep. Carol Murphy [D]	Rep. John Armato [D]	Rep. Valerie Huttle [D]	Rep. BettyLou DeCroce [R]
Rep. Robert Karabinchak [D]

Date	Chamber	Action
2020-02-03	Assembly	Introduced, Referred to Assembly Health Committee

A2488 (Carry Over) 2020-02-03 - Introduced, Referred to Assembly Health Committee
A2488 (Carry Over) 2020-02-03 - Introduced, Referred to Assembly Health Committee
S919 (Same As) 2020-01-27 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
S1590 (Carry Over) 2018-02-05 - Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee
A3987 (Carry Over) 2018-05-17 - Introduced, Referred to Assembly Health and Senior Services Committee

Type	Source
Summary	https://www.njleg.state.nj.us/bill-search/2020/A2488
Text	https://pub.njleg.gov/Bills/2020/A2500/2488_I1.HTM